期刊文献+

肠吉泰联合经皮穴位电刺激法治疗腹泻型肠易激综合征的随机、双盲、安慰剂对照研究 被引量:5

A randomized,double-blinded,placebo-controlled research on Changjitai combined with percutaneous accupoint stimulation in the treatment of diarrhea type irritable bowel syndrome
原文传递
导出
摘要 [目的]观察肠吉泰联合经皮穴位电刺激法治疗腹泻型肠易激综合征(IBS-D)的临床疗效和复发率。[方法]遵循随机、双盲、安慰剂平行对照的设计原则,将242例IBS-D患者分为肠吉泰、肠吉泰联合经皮穴位电刺激、安慰剂3组。按照病情分级特征再次将各组患者分为轻、中、重度进行分层观察研究,以肠道总体症状尺度表评判治疗结果。治疗结束后按1∶1∶1比例将所有治愈和显效的受试者随机分为穴位经皮电刺激组、模拟刺激对照组和空白对照组,电话随访记录受试者复发时间。[结果]肠吉泰和肠吉泰联合经皮穴位电刺激组对肠道总体症状的改善显著优于安慰剂组(P<0.05,<0.01),肠吉泰联合经皮穴位电刺激组较肠吉泰组疗效更显著(P<0.05)。治疗结束后经皮穴位电刺激组的复发率显著低于模拟刺激组和空白对照组(P<0.05)。[结论]经皮穴位电刺激联合肠吉泰比单用肠吉泰治疗有显著的优越性,而且经穴刺激可以有效预防IBS-D的再度复发。 [Objective]To observe the clinical effect and the recurrence rate after treatment of Changjitai combined with percutaneous accupoint stimulation method in the treatment of diarrhea type irritable bowel syndrome. I-Methods]To follow the parallel randomized, double blind, placebo controlled design principle, two hundred and forty-two cases of diarrhea type irritable bowel syndrome patients were divided into Changjitai combined with percutaneous accupoint stimulation and placebo group. According to the patients' condition, each group was sub-divided into mild, medium and heavy layering. Effects were judged according to the bowel symptom scale scores. After the treatment, all cases cured or significantly improved were ran- domly divided into percutaneous accupoint stimulation group, stimulus control group and blank control group, and the telephone follow-up study was made to record the recurrence time. l-Results]Two positive in- terventional groups have got significantly better effects than placebo group. Changjitai combined with per- cutaneous accupoint stimulation group was even better than Changjitai group. After the treatment, recur- rence rate of percutaneous accupoint stimulation group was significantly lower than that of other 2 groups. [Conclusion]Changjitai combined with percutaneous accupoint stimulation group has obvious superiority in improving bowel symptom scale scores,and percutaneous accupoint stimulation can effectively prevent the recurrences of irritable bowel syndrome.
出处 《中国中西医结合消化杂志》 CAS 2014年第1期1-4,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 上海市科委中药现代化专项课题(No:10DZ1973200) 上海中医药事业发展三年行动计划研究型中医院建设项目(No:ZYSNXD-CC-YJXYY-JS13(S)
关键词 腹泻型肠易激综合征 肠吉泰 经穴 电刺激 diarrhea irritable bowel syndrome changitai accupoint percutaneous stimulation
  • 相关文献

参考文献6

二级参考文献31

  • 1袁耀宗,许斌,莫剑忠,王吉耀,李兆申.马来酸曲美布汀治疗肠易激综合征的疗效和安全性研究[J].胃肠病学,2005,10(3):143-147. 被引量:107
  • 2杨欣艳,李世荣.微生态制剂在肠易激综合征治疗中的作用[J].中华医学杂志,2005,85(39):2802-2804. 被引量:16
  • 3蔡淦,雷云霞,郑顺华,李熠萌.肠吉泰治疗腹泻型肠易激综合征60例疗效观察[J].江西中医药,2006,37(5):20-21. 被引量:3
  • 4马晓松,樊雪萍,陈忠,李崇文,邢善.白术对动物胃肠运动的作用及其机制的探讨[J].中华消化杂志,1996,16(5):261-264. 被引量:188
  • 5Saito YA, Schoenfeld, Locke GRI 3rd. The epidemiology of irritable bowel syndrome in North America: a systemic review. Am J Gastroenterol, 2002, 97 : 1910-1915.
  • 6Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmarcol Ther, 2004, 19 : 1217-1224.
  • 7Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology, 2002, 123: 2108-2131.
  • 8Devaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut, 2002, 51(Suppl 1): i67-i71.
  • 9Drossman DA, Ringel Y, Vogt BA, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gasroenterology, 2003, 124:754-761.
  • 10Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut, 2004, 53:1096-1101.

共引文献456

同被引文献82

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部